Skip to content

James Glazer

4 papers in the library · 54 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

B-154: Feasibility of a Randomized Control Trial of a Dream Yoga Intervention

Archives of Clinical Neuropsychology October 1, 2026 A. Purcell, Daniel L. Morris, Jahred Rosa-Sullivan et al.

Objective: Over the past 60 years, contemplative practices have been shown to alleviate certain mental health symptoms. Humans spend approximately one third of their lives asleep, yet there is limited scientific investigation of the benefit of performing contemplative exercises during sleep. Tibetan Buddhist Dream Yoga (TBDY) is a contemplative practice where dreamers perform mental exercises...

Reward-related neural activity after low doses of LSD in participants with depressed mood.

Journal of Psychopharmacology January 13, 2026 James Glazer, Hanna Molla, Royce Lee et al.

Lysergic acid diethylamide (LSD) has been considered as a potential treatment for depression for over 75 years, but its therapeutic potential has only recently been considered in mainstream psychiatry. Repeated ingestion of low doses of LSD ("microdoses") is thought to reduce depression, but the neurobiology underlying this effect is unknown. We previously reported that low doses of LSD...

Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces.

Psychedelic Medicine December 1, 2024 Connor J Haggarty, Hanna Molla, James Glazer et al. 2 citations

Despite widespread popular interest in the use of low doses of Lysergic acid diethylamide (LSD) to improve mood, little is known about how these doses affect emotional processing in the brain. In this study, we tested the effect of a single low dose of LSD (26 µg) compared with placebo on electroencephalogram (EEG) event-related potentials (ERP: N170, P300 and Mismatch Negativity) in healthy...

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity.

Neuropsychopharmacology 2023 James Glazer, Conor H. Murray, Robin Nusslock et al. 52 citations

Renewed interest in classic psychedelics as treatments for psychiatric disorders warrants a deeper understanding of their neural mechanisms. Single, high doses of psychedelic drugs have shown promise in treating depressive disorders, perhaps by reversing deficits in reward processing in the brain. In addition, there are anecdotal reports that repeated ingestion of low doses of LSD, or...